HIV Co-receptor Tropism Detection via Codon Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current assays are inadequate for rapidly and easily detecting viruses with reduced susceptibility to entry inhibitors, and determining whether a virus can enter cells expressing specific co-receptors, which is crucial for developing effective anti-viral treatments for HIV infection.
Innovation Solution
A method involving the detection of specific codons in the HIV envelope protein nucleic acid, such as valine at codon 515 or alanine at codon 607, to predict the virus's ability to enter cells expressing CD4 and CXCR4 or CCR5, using nucleic acid sequencing and expression vectors to assess entry tropism and inhibitor susceptibility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current assays are used to detect viruses with reduced susceptibility to entry inhibitors, then detection can be performed, but the process is not rapid or easy
Solution Approach 1:
The invention extracts and focuses on specific codons (515, 539, 607) in the HIV envelope protein gene that are critical for determining co-receptor usage and inhibitor susceptibility. By isolating and analyzing only these key genetic markers rather than performing comprehensive viral characterization, the assay achieves rapid and easy detection of viruses with reduced susceptibility to entry inhibitors
Solution Approach 2:
The invention replaces complex phenotypic assays (mechanical/cellular methods) with genotypic analysis (molecular biology methods). Instead of performing labor-intensive cell-based entry assays to determine viral susceptibility, the method uses nucleic acid sequencing and analysis of specific codons to predict co-receptor usage and inhibitor effectiveness, dramatically simplifying the detection process
2Measurement precision
If comprehensive viral characterization is performed to determine co-receptor usage, then accurate treatment guidance can be provided, but the process becomes time-consuming and complex
Solution Approach 1:
The invention extracts and analyzes only the critical genetic determinants (codons 515, 539, 607) that control co-receptor binding preferences. This focused approach maintains accurate determination of CCR5 versus CXCR4 usage while eliminating time-consuming comprehensive viral characterization, providing rapid treatment guidance
Solution Approach 2:
The invention performs preliminary genetic analysis of key codons that predict co-receptor usage before initiating treatment decisions. By determining the viral genotype at these critical positions in advance, the method enables rapid selection of appropriate entry inhibitors without waiting for lengthy phenotypic characterization results
Data Source
AI summary
The invention provides a method for determining whether a human immunodeficiency virus is likely to be have enhanced ability to enter a cell expressing CD4 and CXCR4 relative to a reference HIV. In certain aspects, the methods comprise detecting one or more amino acids in an envelope protein of the HIV associated with enhanced ability to enter CD4- and CXCR4-expressing cells and determining that the HIV's ability to enter such cells is enhanced relative to a reference HIV, e.g., an HIV that does not comprise such amino acid(s).